awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38773520-D133C40B-BDB9-4B49-852B-2D31109C0146
Q38773520-D133C40B-BDB9-4B49-852B-2D31109C0146
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38773520-D133C40B-BDB9-4B49-852B-2D31109C0146
Assessing Metabolic Changes in Response to mTOR Inhibition in a Mantle Cell Lymphoma Xenograft Model Using AcidoCEST MRI.
P2860
Q38773520-D133C40B-BDB9-4B49-852B-2D31109C0146
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38773520-D133C40B-BDB9-4B49-852B-2D31109C0146
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9a10204d47984460d8dcc2e407a4f5268020bab6
P2860
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.